Opana and Hyperglycemia - a phase IV clinical study of FDA data

Summary:

Hyperglycemia is reported as a side effect among people who take Opana (oxymorphone hydrochloride), especially for people who are female, 40-49 old, also take Neurontin, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Hyperglycemia when taking Opana. It is created by eHealthMe based on reports of 39,845 people who have side effects when taking Opana from the FDA, and is updated regularly.

What is Opana?

Opana has active ingredients of oxymorphone hydrochloride. It is often used in pain. eHealthMe is studying from 40,340 Opana users. Check the latest studies of Opana.

What is Hyperglycemia?

Hyperglycemia (high blood sugar) is found to be associated with 1,658 drugs and 2,501 conditions by eHealthMe. Check the latest studies of Hyperglycemia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

39,845 people reported to have side effects when taking Opana.
Among them, 15 people (0.04%) have Hyperglycemia.

Among these 15 people:

What is the gender of people who have Hyperglycemia when taking Opana? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Hyperglycemia when taking Opana? *

What are other drugs people take besides Opana? *

What are other side effects people have besides Hyperglycemia? *

Heart Attack: 10 people, 66.67%
Blindness: 9 people, 60.00%
Electrocardiogram St Segment Elevation: 9 people, 60.00%
Ejection Fraction Decreased (systolic heart failure): 9 people, 60.00%
Thrombotic Microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury): 9 people, 60.00%
Pericarditis (inflammation of the pericardium): 9 people, 60.00%
Haemolytic Uraemic Syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more): 9 people, 60.00%
Hypoaesthesia (reduced sense of touch or sensation): 7 people, 46.67%
Abdominal Pain: 7 people, 46.67%
Dyspnea (difficult or laboured breathing): 6 people, 40.00%

What are the existing conditions these people have? *

Stress And Anxiety: 3 people, 20.00%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 20.00%
Nerve Injury: 2 people, 13.33%
Intervertebral Disc Degeneration (spinal disc degeneration): 2 people, 13.33%
Gastric Disorder (disease of stomach): 2 people, 13.33%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 13.33%
Faeces Hard: 1 person, 6.67%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 6.67%
Asthma: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Opana and have Hyperglycemia?

- Check whether Hyperglycemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Opana:

Opana (40,340 reports)

Hyperglycemia treatments and more:

Hyperglycemia (48,691 reports)

Browse all side effects of Opana:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperglycemia:

Hyperglycemia (1,658 drugs)

Browse all the conditions that are associated with Hyperglycemia:

Hyperglycemia (2,501 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on oxymorphone hydrochloride (the active ingredients of Opana) and Opana (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.